Connect with us

News

Microdosing Moms on the Rise as Psychedelics Become More Common

Published

on

As psychedelics become more commonplace as more research is being done on the efficacy of the drugs on a variety of medical conditions, moms are on the rise as a demographic who have been microdosing psilocybin mushrooms, claiming it helps them be better parents.

Moms across the country have become involved in a movement that claims microdosing mushrooms helps develop parenting skills and the “magic” mushroom capsules, usually 0.1 to 0.3 milligrams per dose, allows them to have more patience, more ability to cope, more organizational talent and more happiness while raising a child. A study published in Scientific Reports found psilocybin mushrooms had a noticeable effect on the mood and mental health of participants, with researchers finding microdosing psilocybin could be a viable treatment option.

“It’s not so dangerous that it would be so obvious, but really we don’t have good epidemiological studies. Are there any bad outcomes? Are there good outcomes? There’s still a lot of work to be done,” said Dr. Josh Woolley, an associate psychiatry professor in residence at the University of California San Francisco. “And so people who are using, who are microdosing, what I would say is that they’re basically experimenting on themselves. We really just don’t know that much about it, but it isn’t without risk.”

The U.S. Food and Drug Administration designated psilocybin as a “breakthrough therapy” in 2019 in an effort to speed up the process of drug development and review and is typically requested by a drug company and is granted when preliminary evidence suggests the drug may be more effective than what is already available.

Psychedelics have recently started becoming more mainstream as more drug therapies are developed and results are found showing the efficacy of psychedelic therapy for conditions such as depression, anxiety, post-traumatic stress disorder, as well as being able to help ease patients suffering from terminal illnesses. A recent online poll by YouGov found 28% of Americans have tried one of the seven psychedelic drugs listed on the questionnaire, with LSD being the most used substance (1%) and psilocybin coming in as the second most used (13%). The pattern of acceptance follows areas where legislation surrounding psychedelics has been enacted, with 37% of those who reported psychedelic use living in the western United States.

“Recent shifts, both in policy and public opinion, suggest the tide in the United States may be turning toward increasingly favoring psychedelic drugs,” YouGov said. “In the past few years, a number of cities across the U.S., such as Oakland, California, have decriminalized psilocybin, also known as psychedelic mushrooms. This November, Coloradans will vote on whether to legalize the drug state-wide, and by January 2023, Oregon is expected to begin allowing its use for mental-health treatment in supervised settings.”

Super Bowl Champion quarterback and NFL MVP Aaron Rodgers recently revealed he traveled to South America and took ayahuasca before being selected as the most valuable player in the league two years in a row, stating that after the experience he knew he would ever be the same again.

“For me, I didn’t do that and think ‘oh, I’m never playing football again,'” Rodgers said. “No, it gave me a deep and meaningful appreciation for life. My intention the first night going in was ‘I want to feel what pure love feels like.’ That was my intention. And I did. I really did. I had a magical experience with the sensation of feeling a hundred different hands on my body imparting a blessing of love and forgiveness for myself and gratitude for this life from what seemed to be my ancestors.”